Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2013 2
2014 2
2015 2
2017 1
2018 1
2020 3
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models.
Panagi M, Mpekris F, Chen P, Voutouri C, Nakagawa Y, Martin JD, Hiroi T, Hashimoto H, Demetriou P, Pierides C, Samuel R, Stylianou A, Michael C, Fukushima S, Georgiou P, Papageorgis P, Papaphilippou PC, Koumas L, Costeas P, Ishii G, Kojima M, Kataoka K, Cabral H, Stylianopoulos T. Panagi M, et al. Among authors: pierides c. Nat Commun. 2022 Nov 22;13(1):7165. doi: 10.1038/s41467-022-34744-1. Nat Commun. 2022. PMID: 36418896 Free PMC article.
The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy.
Neophytou CM, Pierides C, Christodoulou MI, Costeas P, Kyriakou TC, Papageorgis P. Neophytou CM, et al. Among authors: pierides c. Front Oncol. 2020 Jun 9;10:899. doi: 10.3389/fonc.2020.00899. eCollection 2020. Front Oncol. 2020. PMID: 32656079 Free PMC article. Review.
Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses.
Lysandrou M, Stamou P, Kefala D, Pierides C, Kyriakou M, Savvopoulos N, Christofi P, Papadopoulou A, Yannaki E, Costeas P, Spyridonidis A. Lysandrou M, et al. Among authors: pierides c. Front Immunol. 2023 Sep 27;14:1235661. doi: 10.3389/fimmu.2023.1235661. eCollection 2023. Front Immunol. 2023. PMID: 37828996 Free PMC article.
General mutation databases: analysis and review.
George RA, Smith TD, Callaghan S, Hardman L, Pierides C, Horaitis O, Wouters MA, Cotton RG. George RA, et al. Among authors: pierides c. J Med Genet. 2008 Feb;45(2):65-70. doi: 10.1136/jmg.2007.052639. Epub 2007 Sep 24. J Med Genet. 2008. PMID: 17893115 Free article. Review.
Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer's disease.
Fella E, Papacharalambous R, Kynigopoulos D, Ioannou M, Derua R, Christodoulou C, Stylianou M, Karaiskos C, Kagiava A, Petroula G, Pierides C, Kyriakou M, Koumas L, Costeas P, Panayiotou E. Fella E, et al. Among authors: pierides c. Front Immunol. 2022 Aug 26;13:947071. doi: 10.3389/fimmu.2022.947071. eCollection 2022. Front Immunol. 2022. PMID: 36091045 Free PMC article.
Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis.
Mpekris F, Panagi M, Voutouri C, Martin JD, Samuel R, Takahashi S, Gotohda N, Suzuki T, Papageorgis P, Demetriou P, Pierides C, Koumas L, Costeas P, Kojima M, Ishii G, Constantinidou A, Kataoka K, Cabral H, Stylianopoulos T. Mpekris F, et al. Among authors: pierides c. Adv Sci (Weinh). 2020 Dec 13;8(3):2001917. doi: 10.1002/advs.202001917. eCollection 2021 Feb. Adv Sci (Weinh). 2020. PMID: 33552852 Free PMC article.
Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.
Chi J, Nicolaou KA, Nicolaidou V, Koumas L, Mitsidou A, Pierides C, Manoloukos M, Barbouti K, Melanthiou F, Prokopiou C, Vassiliou GS, Costeas P. Chi J, et al. Among authors: pierides c. Leukemia. 2014 May;28(5):1152-4. doi: 10.1038/leu.2013.382. Epub 2013 Dec 24. Leukemia. 2014. PMID: 24365789 Free PMC article. No abstract available.
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
Panagi M, Voutouri C, Mpekris F, Papageorgis P, Martin MR, Martin JD, Demetriou P, Pierides C, Polydorou C, Stylianou A, Louca M, Koumas L, Costeas P, Kataoka K, Cabral H, Stylianopoulos T. Panagi M, et al. Among authors: pierides c. Theranostics. 2020 Jan 12;10(4):1910-1922. doi: 10.7150/thno.36936. eCollection 2020. Theranostics. 2020. PMID: 32042344 Free PMC article.
15 results